Netazepide, a gastrin/CCK2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis

Autor:	Reidar Fossmark, David M. Pritchard, Andrea Varro, Bryony N. Parsons, Liv Thomsen, Helge L. Waldum, Andrew R. Moore, Katie A. Lloyd, Liv Sagatun, Malcolm Boyce
Rok vydání:	2016
Předmět:	Cck2 receptor medicine.medical_specialty business.industry Atrophic gastritis Internal medicine Netazepide medicine Antagonist In patient business medicine.disease Gastroenterology Gastrin
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
DOI:	10.1530/endoabs.46.oc1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::38682029a0f10e6376c9c13bbbd8447a https://doi.org/10.1530/endoabs.46.oc1 Zobrazit plný text záznamu